Drugs & OTC

Akebia Therapeutics (AKBA) 'Buy' Rating Reiterated with Higher Stock Price Target of $18

🕔12/2/2016 8:30:00 AM

Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharma company that focuses on the development of innovative treatments for chronic kidney disease-related anemia, is maintaining its 'Buy' rating, with a recommended stock price target of $18 compared to the current $8.90, according to an Aegis Capital Corp. report (http://nnw.fm/F4ezY) released on November 15. The rating and suggested stock price were based on discounted cash flow analysis and the estimated 2016-2022 EBITDA, with a discount rate of eight percent, the report said.

Read Full Article▸

Zogenix, Inc. (ZGNX) Develops Orphan Drug for Dravet Syndrome Epilepsy

🕔12/1/2016 8:30:00 AM

Zogenix, Inc (NASDAQ:ZGNX) is a clinical stage pharmaceutical company committed to the development and commercialization of therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases. The company's lead product candidate, ZX008, is currently being evaluated for the treatment of one such disease - Dravet Syndrome.

Read Full Article▸

MMJ PhytoTech Ltd (ASX:MMJ) AGM Presentation

🕔11/28/2016 1:14:36 PM

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide the company's AGM Presentation with the topic "Developing a World-Class Pure Play Cannabis Company".

Read Full Article▸

MMJ PhytoTech Ltd (ASX:MMJ) United Greeneries Receives Cannabis Seed Import Permit

🕔11/28/2016 8:26:11 AM

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that its Canadian subsidiary, United Greeneries Ltd, has received an Import Permit from Health Canada and the Canadian Food Inspection Agency, allowing for the importation of 1kg of cannabis seeds. Importantly, this will enable UG to commence cultivation activities at the Duncan Facility in December.

Read Full Article▸

Anatara Lifesciences Ltd (ASX:ANR) Investor Update

🕔11/22/2016 8:27:13 AM

Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its updated investor presentation.

Read Full Article▸

Anatara Lifesciences Ltd (ASX:ANR) AGM Presentation

🕔11/15/2016 11:51:40 AM

Anatara Lifesciences Ltd (ASX:ANR) is pleased to provide the company's AGM Presentation held on 15 November 2016.

Read Full Article▸

Anatara Lifesciences Ltd (ASX:ANR) Chairman's Address to Shareholders

🕔11/15/2016 11:50:40 AM

Anatara Lifesciences Ltd (ASX:ANR) is pleased to provide the company's latest Chairman's Address to Shareholders at 2016 AGM.

Read Full Article▸

Banking & Finance

Read More

Oil Gas & Energy

Read More

Life Sciences

Read More

Social Media

Latest Headlines